ClinicalTrials.gov
ClinicalTrials.gov Menu

Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01673217
Recruitment Status : Completed
First Posted : August 27, 2012
Last Update Posted : January 13, 2014
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Eisai Inc.
Information provided by (Responsible Party):
Roswell Park Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2011
  Actual Study Completion Date : June 2013